Effect of a 12-month Pharmaceutical Care Program on Control of Severe Asthma
- Conditions
- AsthmaQuality of Life
- Interventions
- Other: Pharmaceutical care
- Registration Number
- NCT01644357
- Lead Sponsor
- Federal University of Bahia
- Brief Summary
Only a few well-designed studies have investigated the effect of pharmaceutical care on asthma patients and to date there are no published studies investigating this effect specifically on severe and refractory asthma.
The objective of this study is evaluate the effect of pharmaceutical care on asthma control and quality of life (QoL) of patients with severe or refractory asthma compared with pharmacist dispensation only.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
- Patients with severe/refractory asthma presenting other respiratory disease,
- ≥ 18 years of age,
- using high dose of inhaled corticosteroids (≥ 800mcg of budesonide or equivalent)
- FEV1<60%,
- regular visitor of the pharmacy and the physicians.
- participation in other intervention study during this study,
- living in other cities,
- could not participate in all visits of the study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Pharmaceutical care Pharmaceutical care Patients on experimental group will receive counseling and education on the asthma condition, medication and lifestyle issues. In all visits, the inhaler technique will be reviewed, adherence to treatment and drug related problems were checked. If necessary the patient will be referred to the respiratory specialist to change the medication or to prescribe dose adjustment. Pharmacists document their initial and monthly follow up encounters using a specified form.
- Primary Outcome Measures
Name Time Method asthma control of symptoms 12 months Measured by Asthma Control Questionnaire and medical evaluation
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Program for Asthma Control (ProAR) of the Federal University of Bahia
🇧🇷Salvador, Bahia, Brazil